Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2004
10/12/2004US6803384 Diaminopropionic acid derivatives
10/07/2004WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
10/07/2004WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
10/07/2004WO2004085384A2 Bis-aryl sulfonamides
10/07/2004WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004WO2004084813A2 Chemical compounds
10/07/2004WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors
10/07/2004US20040198749 Methods of using sodium channel blockers
10/07/2004US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004US20040198747 Sodium channel blockers
10/07/2004US20040198746 Sodium channel blockers
10/07/2004US20040198745 Sodium channel blockers
10/07/2004US20040198744 Methods of using phenolic guanidine sodium channel blockers
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
10/07/2004CA2505590A1 Bis-aryl sulfonamides
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1169312B1 Glucokinase activators
10/06/2004EP1135379B1 Antitumor dibenzofluorene derivatives
10/06/2004CN1169791C Novel acetamide derivatives and protease inhibitors
10/05/2004CA2282834C Novel hexanoic acid derivatives
09/2004
09/30/2004WO2004083173A2 Ketopiperazine derivatives as bradykinin antagonists
09/30/2004WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
09/30/2004WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004WO2003022785A3 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
09/30/2004US20040192702 Heteroaryl alkyl piperazine derivatives
09/30/2004US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain
09/30/2004US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto
09/29/2004EP1463130A2 P-type materials and mixtures for electronic devices
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
09/29/2004CN1533382A 哌嗪衍生物 Piperazine derivatives
09/29/2004CN1532959A P type material and mikture used for electronic device
09/29/2004CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
09/29/2004CN1168700C Cyclic amine substd. phenylalkanone and preparing method thereof
09/28/2004US6797848 Anthracene derivative and organic electroluminescence device using the derivative
09/28/2004US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
09/28/2004US6797706 Heterocyclecarboxamide derivative
09/28/2004CA2201218C Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
09/23/2004WO2004081643A1 Lenslet array with polarization conversion
09/23/2004WO2004080982A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
09/23/2004WO2004080978A1 Amide compound and bactericidal composition comprising the same
09/23/2004WO2004080958A2 Process to tetrahydrotriazolopyrazines and intermediates
09/23/2004WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis
09/23/2004US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3
09/23/2004US20040183066 P-type materials and mixtures for electronic devices
09/23/2004CA2517720A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
09/22/2004EP1460066A1 Piperazine compounds
09/22/2004EP1458719A1 Pyridoquinoxaline antivirals
09/22/2004EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
09/22/2004EP1458689A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
09/22/2004EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives
09/22/2004EP1458393A1 Substituted diketopiperazines as oxytocin antagonists
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
09/21/2004US6794507 Compounds that inhibit factor Xa activity
09/21/2004US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794392 Cell differentiation inducer
09/21/2004US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters
09/21/2004US6794373 Contraceptive methods using benzimidazolones
09/21/2004US6794372 Nitrate salts of antimicrobial agents
09/16/2004WO2004078714A2 Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazouinoxalines and heterocyclic-substituted imidazopyrazines
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181075 Process of making chalcone derivatives
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180947 Sulfonamide compounds and pharmaceutical use thereof
09/16/2004US20040180905 for treating cancer and fibrotic diseases
09/16/2004US20040180898 chemical reduction reaction
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/15/2004EP1456208A1 Pyridoquinoxaline antivirals
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1529756A Steroselective preparation of cyclic L-amino acids
09/15/2004CN1529699A Novel sulfonic acid derivatives
09/15/2004CN1166646C Process for synthesis of azacyclic compounds
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076386A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2003084982A3 Functionalized compositions for improved immobilization
09/10/2004CA2516842A1 Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176426 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids
09/09/2004US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase
09/09/2004US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity
09/09/2004US20040176386 Compounds
09/08/2004EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them.
09/08/2004EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors